Investor Relations

Get stock updates, FAQs, and more.

go to Investor Relations

Our Best-in-Class Companies

Find a powerful partner that promises results.

find an inVentiv Health company

Contact Information

If you are representing a media outlet and have immediate questions, please contact:

MARCIA FREDERICK
614.543.6281
mfrederick@inventivhealth.com

Press Releases

Chandler Chicco Named "Healthcare Agency of the Decade" by The Holmes Report

January 19, 2009 -- New York, NY – Chandler Chicco, part of inVentiv Health [NASDAQ: VTIV], was named ‘Healthcare Agency of the Decade’ in the January 9 issue of The Holmes Report, an online publication which reports public relations industry news, trends and analysis.  The report lauded Chandler Chicco’s growth and prosperity as a specialist agency, stating the agency is “perhaps the fastest-growing midsized firm of the past 10 years.”

Chandler Chicco was one of five specialist agencies recognized by the report as continuing to flourish throughout the past decade, outperforming many large global agencies.  The report notes that over the past decade, the agency "became a benchmark for quality in healthcare communications, built a roster that includes almost every major pharmaceutical company in the world, grew its European operations until it was the largest healthcare specialist in the region, remained a fixture on our ‘Best Agency to Work For’ list, and won awards in the U.S. and Europe for its creative and strategic programming.”

“We are extremely honored by the award and the accompanying article from The Holmes Report,” said Chandler Chicco co-founder Bob Chandler. “We are particularly grateful to our clients and employees for helping us to achieve such success over the past decade.”
 
Since 2000, Chandler Chicco has quadrupled in size, expanded into European markets, developed design, research and advertising capabilities, and became part of healthcare services holding company inVentiv Health in 2007. The agency currently offers public relations and communications counsel to a list of over 40 clients, including hospitals, NGOs, healthcare associations, coalitions, and many of the world’s largest pharmaceutical companies.

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: our ability to sufficiently increase our revenues and maintain or decrease expenses and cash capital expenditures to permit us to fund our operations; our ability to continue to comply with the covenants and terms of our credit facility and to access sufficient capital to fund our operations; our ability to grow our existing client relationships, obtain new clients and cross-sell our services; our ability to successfully operate new lines of business; our ability to manage our infrastructure and resources to support our growth; our ability to successfully identify new businesses to acquire, conclude acquisition negotiations and integrate the acquired businesses into our operations; any disruptions, impairments, or malfunctions affecting software as well as excessive costs or delays that may adversely impact our continued investment in and development of software; the potential impact of government regulation on us and on our clients base; our ability to comply with all applicable laws as well as our ability to successfully implement from a timing and cost perspective any changes in applicable laws; our ability to recruit, motivate and retain qualified personnel, including sales representatives; the actual impact of the adoption of certain accounting standards; our ability to maintain technological advantages in a variety of functional areas, including sales force automation, electronic claims surveillance and patient compliance; changes in trends in the healthcare and pharmaceutical industries or in pharmaceutical outsourcing; and our inability to determine the actual time at which the liquidation of the Columbia Strategic Cash Portfolio will be completed or the total losses that we will actually realize from that investment vehicle. . Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.